UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000031291
Receipt No. R000035724
Official scientific title of the study To assess the usefulness of new EBUS-TBNA needle.
Date of disclosure of the study information 2018/02/20
Last modified on 2018/02/14 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study To assess the usefulness of new EBUS-TBNA needle.
Title of the study (Brief title) To assess the usefulness of new EBUS-TBNA needle.
Region
Japan

Condition
Condition Non-small cell lung cancer with advanced stage
Classification by specialty
Medicine in general Pneumology Chest surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effectiveness of new EBUS-TBNA needle.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Yields of adequate tissue specimen sampling
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Patients with enlarged mediastinal and/or hilar lesions 10 mm or greater in short-axis diameter on CT or FDG uptaken 2.5 or
higher in PET/CT imaging requiring diagnostic EBUS-TBNA
2. 20 years old and above
3. Informed consent
Key exclusion criteria 1.Patients requiring EBUS-TBNA for N-stage in patients with lung cancer
2.Serious concomitant medical illness
Target sample size 40

Research contact person
Name of lead principal investigator Toshiyuki Nakai
Organization National Cancer Center Hospital
Division name Department of Endoscopy, Respiratory Endoscopy Division
Address 5-1-1, Tukiji Chou-ku, Tokyo, Japan
TEL 03-3542-2511
Email tnakai@ncc.go.jp

Public contact
Name of contact person Toshiyuki Nakai
Organization National Cancer Center Hospital
Division name Department of Endoscopy, Respiratory Endoscopy Division
Address 5-1-1, Tukiji Chou-ku, Tokyo, Japan
TEL 03-3542-2511
Homepage URL
Email tnakai@ncc.go.jp

Sponsor
Institute National Cancer Center Hospital
Institute
Department

Funding Source
Organization The National Cancer Center Research and Development Fund
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 20 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2018 Year 02 Month 12 Day
Anticipated trial start date
2018 Year 02 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information The trial does not start.

Management information
Registered date
2018 Year 02 Month 14 Day
Last modified on
2018 Year 02 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035724